Prednisone modified release - Sun Pharmaceutical Industries

Drug Profile

Prednisone modified release - Sun Pharmaceutical Industries

Alternative Names: Prednisone MR - Sun Pharmaceutical Industries

Latest Information Update: 01 Aug 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Sun Pharmaceutical Industries
  • Class Anti-inflammatories; Antiallergics; Antineoplastics; Antirheumatics; Corticosteroids; Glucocorticoids; Pregnadienediols; Small molecules
  • Mechanism of Action Glucocorticoid receptor agonists; Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase III Rheumatoid arthritis

Most Recent Events

  • 10 Jan 2017 Biomarkers information updated
  • 12 Sep 2016 Sun Pharma Laboratories plans a phase III trial for Rheumatoid arthritis (Treatment-experienced) in India (PO) (CTRI2016-04-006821)
  • 13 Apr 2016 Clinical trials in Rheumatoid arthritis in India (PO) before April 2016
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top